Dutasteride in the treatment of benign prostatic hyperplasia: an update / 中华男科学杂志
National Journal of Andrology
;
(12): 63-67, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-266209
ABSTRACT
Benign prostatic hyperplasia (BPH) is a common disease in older men. At present, 5alpha reductase inhibitor-based medication, preferred by most BPH patients as the first-choice therapy, is taking place of traditional transurethral resection of the prostate. This article presents an update of the researches on the treatment of BPH with dutasteride--a novel 5 alpha-reductase inhibitor.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prostatic Hyperplasia
/
Azasteroids
/
Therapeutic Uses
/
Drug Therapy
/
5-alpha Reductase Inhibitors
/
Dutasteride
Limits:
Humans
/
Male
Language:
Chinese
Journal:
National Journal of Andrology
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS